IL156776A0 - Inhibitors of cruzipain and other cysteine proteases - Google Patents

Inhibitors of cruzipain and other cysteine proteases

Info

Publication number
IL156776A0
IL156776A0 IL15677602A IL15677602A IL156776A0 IL 156776 A0 IL156776 A0 IL 156776A0 IL 15677602 A IL15677602 A IL 15677602A IL 15677602 A IL15677602 A IL 15677602A IL 156776 A0 IL156776 A0 IL 156776A0
Authority
IL
Israel
Prior art keywords
cruzipain
inhibitors
cysteine proteases
proteases
cysteine
Prior art date
Application number
IL15677602A
Other languages
English (en)
Original Assignee
Amura Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0101204.6A external-priority patent/GB0101204D0/en
Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd
Publication of IL156776A0 publication Critical patent/IL156776A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15677602A 2001-01-17 2002-01-17 Inhibitors of cruzipain and other cysteine proteases IL156776A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0101204.6A GB0101204D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
US27550601P 2001-03-13 2001-03-13
PCT/GB2002/000194 WO2002057246A2 (en) 2001-01-17 2002-01-17 Inhibitors of cruzipain and other cysteine proteases

Publications (1)

Publication Number Publication Date
IL156776A0 true IL156776A0 (en) 2004-02-08

Family

ID=26245574

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15677602A IL156776A0 (en) 2001-01-17 2002-01-17 Inhibitors of cruzipain and other cysteine proteases

Country Status (7)

Country Link
US (1) US6958358B2 (https=)
EP (1) EP1358176A2 (https=)
JP (1) JP2004520365A (https=)
CA (1) CA2434068A1 (https=)
IL (1) IL156776A0 (https=)
NZ (1) NZ526912A (https=)
WO (1) WO2002057246A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004523506A (ja) * 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物
US20040147503A1 (en) * 2002-06-04 2004-07-29 Sheila Zipfeil Novel compounds and compositions as cathepsin inhibitors
CA2569887A1 (en) 2004-06-09 2005-12-22 Glaxo Group Limited Pyrrolopyridine derivatives
AU2006316321A1 (en) * 2005-11-22 2007-05-31 Merck & Co., Inc. Indole orexin receptor antagonists
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
EP2719700A1 (en) 2008-01-09 2014-04-16 Amura Therapeutics Limited Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases
US20110046044A1 (en) * 2009-08-24 2011-02-24 Samsung Electronics Co., Ltd. Use of a cysteine protease of Plasmodium vivax
US9409880B2 (en) 2011-01-20 2016-08-09 The Regents Of The University Of Colorado, A Body Corporate Modulators of TLR3/dsRNA complex and uses thereof
WO2026037930A1 (en) * 2024-08-16 2026-02-19 Anavo Therapeutics Bv Amide derivatives as wip1 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652574A (en) 1970-04-01 1972-03-28 Abbott Lab Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
EP0923535A4 (en) 1996-08-28 2001-01-10 Smithkline Beecham Corp CYSTEINE PROTEASE INHIBITORS
EA002100B1 (ru) 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
CO5150165A1 (es) * 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
GB9911417D0 (en) * 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
JP2004513942A (ja) 2000-11-17 2004-05-13 メディヴァー　ユーケイ　リミテッド システインプロテアーゼインヒビター
JP2004523506A (ja) 2000-12-22 2004-08-05 アクシス・ファーマシューティカルズ・インコーポレイテッド カテプシン阻害剤としての新規な化合物と組成物

Also Published As

Publication number Publication date
CA2434068A1 (en) 2002-07-25
EP1358176A2 (en) 2003-11-05
WO2002057246A2 (en) 2002-07-25
US6958358B2 (en) 2005-10-25
NZ526912A (en) 2005-02-25
WO2002057246A3 (en) 2002-11-21
US20040106805A1 (en) 2004-06-03
JP2004520365A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
PL370766A1 (en) Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
HU0304052D0 (en) Heterocyclic inhibitors of erk2 and uses thereof
EP1383743A4 (en) DOUBLE INHIBITORS OF PDE 7 AND PDE 4
AU2002328946A1 (en) Irreversible cysteine protease inhibitors of legumain
PL374221A1 (en) Antibody inhibitors of gdf-8 and uses thereof
AU2003303128A8 (en) Inhibitors and methods of use thereof
PL353535A1 (en) Application of selective pde 10 inhibitor and application of papaverine
NO20042229L (no) Type 4-fosfodiestemseinhibitorer og anvendelse derav
EP1507756A4 (en) CCR9 INHIBITORS AND USE THEREOF
GB0125445D0 (en) Protease Inhibitors
AU2002305926A1 (en) Cysteine protease inhibitors
DE60106968D1 (de) Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
EP1673336A4 (en) CATHEPSINCYSTEINPROTEASEHEMMER
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
IL156776A0 (en) Inhibitors of cruzipain and other cysteine proteases
IL156775A0 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
EP1115390A4 (en) HYDROXAMATE-CONTAINING INHIBITORS OF THE CYSTEIN AND SERINE PROTEASES
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
SI1616007T1 (sl) Inhibitor proteini proteaze in njih uporaba
EP1401453A4 (en) PROTEASE INHIBITORS
IL160230A0 (en) Use of il-18 inhibitors
IL155961A0 (en) Cysteine protease inhibitors
ZA200305260B (en) Inhibitors of cruzipain and other cysteine proteases.
ZA200305259B (en) Inhibitors of cruzipain and other cysteine proteases.
AU2002219398A1 (en) Inhibitors of cruzipain and other cysteine proteases